Phase I clinical trial of DISC-GMCSF for immunotherapy of metastatic melanoma

被引：0
|
作者：
Loudon, PT
Choolun, E
Curry, J
Day, DA
Duncan, IA
Entwisle, C
Lowden, RC
McLean, CS
Martin, G
Shaw, ML
Gore, M
Harris, AL
Ali, SA
Lynam, J
Rees, RC
机构：
[1] Xenova, Cambridge CB4 0WG, England
[2] Royal Marsden NHS Trust, London SW3 6JJ, England
[3] Churchill Hosp, Imperial Canc Res Fund, Med Oncol Unit, Oxford OX3 7LJ, England
[4] Nottingham Trent Univ, Nottingham NG11 8NS, England
来源：
CANCER GENE THERAPY | 2001年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O78
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
    Algazi, A. P.
    Weber, J. S.
    Andrews, S. C.
    Urbas, P.
    Munster, P. N.
    DeConti, R. C.
    Hwang, J.
    Sondak, V. K.
    Messina, J. L.
    McCalmont, T.
    Daud, A. I.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 85 - 91
  • [2] Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
    A P Algazi
    J S Weber
    S C Andrews
    P Urbas
    P N Munster
    R C DeConti
    J Hwang
    V K Sondak
    J L Messina
    T McCalmont
    A I Daud
    British Journal of Cancer, 2012, 106 : 85 - 91
  • [3] Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
    Exley, Mark A.
    Friedlander, Phillip
    Alatrakchi, Nadia
    Vriend, Lianne
    Yue, Simon
    Sasada, Tetsuro
    Zeng, Wanyong
    Mizukami, Yo
    Clark, Justice
    Nemer, David
    LeClair, Kenneth
    Canning, Christine
    Daley, Heather
    Dranoff, Glenn
    Giobbie-Hurder, Anita
    Hodi, F. Stephen
    Ritz, Jerome
    Balk, Steven P.
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3510 - 3519
  • [4] Phase I/II clinical trial of immunotherapy by intratumoral administration of dendritic cells for patients with melanoma
    Saito, Masataka
    Fujita, Tomonobu
    Tanikawa, Akiko
    Ishida, Akaru
    Sakurai, Toshiharu
    Handa, Makoto
    Amagai, Masayuki
    Kawakami, Yutaka
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 328 - 328
  • [5] A phase I/II trial of DTIC and dasatinib in metastatic melanoma
    Algazi, A. P.
    Weber, J. S.
    Andrews, S.
    Urbas, P.
    Arimura, E.
    Hwang, J.
    Sondak, V. K.
    Bastian, B.
    Daud, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma
    Camacho, Luis H.
    Antonia, Scott
    Sosman, Jeffrey
    Kirkwood, John M.
    Gajewski, Thomas F.
    Redman, Bruce
    Pavlov, Dmitri
    Bulanhagui, Cecile
    Bozon, Viviana A.
    Gomez-Navarro, Jesus
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1075 - 1081
  • [7] PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTRYN, JC
    LEVIN, M
    SPEYER, S
    HARRIS, M
    ROSES, D
    BERNSTEIN, P
    CLINICAL RESEARCH, 1984, 32 (02): : A574 - A574
  • [8] PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTTRYN, JC
    LEVIN, M
    SPEYER, S
    HARRIS, M
    ROSES, D
    BERNSTEIN, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (04) : 425 - 426
  • [9] A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma
    Hiniker, S. M.
    Reddy, S. A.
    Maecker, H. T.
    Swetter, S. M.
    Shura, L.
    Knox, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E95 - E95
  • [10] A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma
    Hiniker, Susan M.
    Reddy, Sunil A.
    Maecker, Holden T.
    Subrahmanyam, Priyanka B.
    Rosenberg-Hasson, Yael
    Swetter, Susan M.
    Saha, Saurabh
    Shura, Lei
    Knox, Susan J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (03): : 578 - 588
12345